{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T01:48:39Z","timestamp":1792288119560,"version":"4.4.0"},"reference-count":46,"publisher":"American Society of Hematology","issue":"12","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2012,3,22]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The BCR-ABL fusion protein generated by t(9;22)(q34;q11) in chronic myeloid leukemia (CML) plays an essential role in the pathogenesis of the myeloproliferative disorder status at the chronic phase of the disease, but progression from the chronic phase to blast crisis (BC) is believed to require additional mutations. To explore the underlying mechanisms for BC, which is characterized by a blockage of blood cell differentiation, we screened several genes crucial to hematopoiesis and identified 10 types of mutations in RUNX1 among 11 of 85 (12.9%) patients with acute transformation of CML. Most of the mutations occurred in the runt homology domain, including H78Q, W79C, R139G, D171G, R174Q, L71fs-ter94, and V91fs-ter94. Further studies indicated that RUNX1 mutants not only exhibited decreased transactivation activity but also had an inhibitory effect on the WT RUNX1. To investigate the leukemogenic effect of mutated RUNX1, H78Q and V91fs-ter94 were transduced into 32D cells or BCR-ABL\u2013harboring murine cells, respectively. Consistent with the myeloblastic features of advanced CML patients with RUNX1 mutations, H78Q and V91fs-ter94 disturbed myeloid differentiation and induced a BC or accelerated phase\u2013like phenotype in mice. These results suggest that RUNX1 abnormalities may promote acute myeloid leukemic transformation in a subset of CML patients.<\/jats:p>","DOI":"10.1182\/blood-2011-08-370981","type":"journal-article","created":{"date-parts":[[2012,2,8]],"date-time":"2012-02-08T07:20:40Z","timestamp":1328685640000},"page":"2873-2882","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":46,"title":["Functional features of RUNX1 mutants in acute transformation of chronic myeloid leukemia and their contribution to inducing murine full-blown leukemia"],"prefix":"10.1182","volume":"119","author":[{"given":"Li-Juan","family":"Zhao","sequence":"first","affiliation":[{"name":"State Key Laboratory of Medical Genomics, Institute of Health Sciences, Shanghai Institutes for Biological Sciences and Graduate School, Chinese Academy of Sciences and Shanghai Institute of Hematology, Rui Jin Hospital, affiliated with Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue-Ying","family":"Wang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Medical Genomics, Institute of Health Sciences, Shanghai Institutes for Biological Sciences and Graduate School, Chinese Academy of Sciences and Shanghai Institute of Hematology, Rui Jin Hospital, affiliated with Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo","family":"Li","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Medical Genomics, Institute of Health Sciences, Shanghai Institutes for Biological Sciences and Graduate School, Chinese Academy of Sciences and Shanghai Institute of Hematology, Rui Jin Hospital, affiliated with Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Yuan","family":"Ma","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Medical Genomics, Institute of Health Sciences, Shanghai Institutes for Biological Sciences and Graduate School, Chinese Academy of Sciences and Shanghai Institute of Hematology, Rui Jin Hospital, affiliated with Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Min","family":"Xiong","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Medical Genomics, Institute of Health Sciences, Shanghai Institutes for Biological Sciences and Graduate School, Chinese Academy of Sciences and Shanghai Institute of Hematology, Rui Jin Hospital, affiliated with Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-Qin","family":"Weng","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Medical Genomics, Institute of Health Sciences, Shanghai Institutes for Biological Sciences and Graduate School, Chinese Academy of Sciences and Shanghai Institute of Hematology, Rui Jin Hospital, affiliated with Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Na","family":"Zhang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Medical Genomics, Institute of Health Sciences, Shanghai Institutes for Biological Sciences and Graduate School, Chinese Academy of Sciences and Shanghai Institute of Hematology, Rui Jin Hospital, affiliated with Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Wu","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Medical Genomics, Institute of Health Sciences, Shanghai Institutes for Biological Sciences and Graduate School, Chinese Academy of Sciences and Shanghai Institute of Hematology, Rui Jin Hospital, affiliated with Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhu","family":"Chen","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Medical Genomics, Institute of Health Sciences, Shanghai Institutes for Biological Sciences and Graduate School, Chinese Academy of Sciences and Shanghai Institute of Hematology, Rui Jin Hospital, affiliated with Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sai-Juan","family":"Chen","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Medical Genomics, Institute of Health Sciences, Shanghai Institutes for Biological Sciences and Graduate School, Chinese Academy of Sciences and Shanghai Institute of Hematology, Rui Jin Hospital, affiliated with Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"10","key":"2019111808002015500_B1","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1182\/blood.V96.10.3343","article-title":"The molecular biology of chronic myeloid leukemia.","volume":"96","author":"Deininger","year":"2000","journal-title":"Blood"},{"issue":"19","key":"2019111808002015500_B2","doi-asserted-by":"crossref","first-page":"4702","DOI":"10.1182\/blood-2007-05-088724","article-title":"Enhanced expression of p210BCR\/ABL and aberrant expression of Zfp423\/ZNF423 induce blast crisis of chronic myelogenous leukemia.","volume":"113","author":"Miyazaki","year":"2009","journal-title":"Blood"},{"issue":"3","key":"2019111808002015500_B3","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/nrc1567","article-title":"Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia.","volume":"5","author":"Ren","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"2019111808002015500_B4","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1182\/asheducation-2008.1.436","article-title":"Chronic myeloid leukemia stem cells.","volume":"2008","author":"Jamieson","year":"2008","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"2019111808002015500_B5","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1182\/asheducation-2007.1.384","article-title":"The biology of CML blast crisis.","volume":"2007","author":"Radich","year":"2007","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"11","key":"2019111808002015500_B6","doi-asserted-by":"crossref","first-page":"4010","DOI":"10.1182\/blood-2003-12-4111","article-title":"The biology of CML blast crisis.","volume":"103","author":"Calabretta","year":"2004","journal-title":"Blood"},{"issue":"57","key":"2019111808002015500_B7","doi-asserted-by":"crossref","first-page":"8236","DOI":"10.1038\/sj.onc.1205095","article-title":"Cooperation of BCR-ABL and AML1\/MDS1\/EVI1 in blocking myeloid differentiation and rapid induction of an acute myelogenous leukemia.","volume":"20","author":"Cuenco","year":"2001","journal-title":"Oncogene"},{"issue":"12","key":"2019111808002015500_B8","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.1182\/blood-2002-04-1244","article-title":"Oncogenic interaction between BCR-ABL and NUP98-HOXA9 demonstrated by the use of an in vitro purging culture system.","volume":"100","author":"Mayotte","year":"2002","journal-title":"Blood"},{"issue":"22","key":"2019111808002015500_B9","doi-asserted-by":"crossref","first-page":"12359","DOI":"10.1073\/pnas.93.22.12359","article-title":"Absence of fetal liver hematopoiesis in mice deficient in transcriptional coactivator core binding factor beta.","volume":"93","author":"Sasaki","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"2019111808002015500_B10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/blood.V86.1.1.bloodjournal8611","article-title":"Aml1 and the 8-21 and 3-21 Translocations in Acute and Chronic Myeloid-Leukemia.","volume":"86","author":"Nucifora","year":"1995","journal-title":"Blood"},{"issue":"6","key":"2019111808002015500_B11","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1182\/blood.V93.6.1817.406k36_1817_1824","article-title":"Biallelic and heterozygous point mutations in the runt domain of the AML1\/PEBP2alphaB gene associated with myeloblastic leukemias.","volume":"93","author":"Osato","year":"1999","journal-title":"Blood"},{"issue":"12","key":"2019111808002015500_B12","first-page":"1307","article-title":"Core binding factor genes and human leukemia.","volume":"87","author":"Hart","year":"2002","journal-title":"Haematologica"},{"issue":"26","key":"2019111808002015500_B13","doi-asserted-by":"crossref","first-page":"5352","DOI":"10.1182\/blood-2009-05-223784","article-title":"AML1\/RUNX1 mutations in 470 adult patients with de novo acute myeloid leukemia: prognostic implication and interaction with other gene alterations.","volume":"114","author":"Tang","year":"2009","journal-title":"Blood"},{"issue":"22","key":"2019111808002015500_B14","doi-asserted-by":"crossref","first-page":"8443","DOI":"10.1073\/pnas.0402063101","article-title":"Modeling first-hit functions of the t(12;21) TEL-AML1 translocation in mice.","volume":"101","author":"Tsuzuki","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"2019111808002015500_B15","doi-asserted-by":"crossref","first-page":"3735","DOI":"10.1182\/blood-2007-07-102533","article-title":"RUNX1 DNA-binding mutations and RUNX1-PRDM16 cryptic fusions in BCR-ABL+ leukemias are frequently associated with secondary trisomy 21 and may contribute to clonal evolution and imatinib resistance.","volume":"111","author":"Roche-Lestienne","year":"2008","journal-title":"Blood"},{"issue":"3","key":"2019111808002015500_B16","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/leu.2010.298","article-title":"A deep-sequencing study of chronic myeloid leukemia patients in blast crisis (BC-CML) detects mutations in 76.9% of cases.","volume":"25","author":"Grossmann","year":"2011","journal-title":"Leukemia"},{"issue":"6","key":"2019111808002015500_B17","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1073\/pnas.0711824105","article-title":"Gain-of-function mutation of GATA-2 in acute myeloid transformation of chronic myeloid leukemia.","volume":"105","author":"Zhang","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"2019111808002015500_B18","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1073\/pnas.1019625108","article-title":"C-KIT mutation cooperates with full-length AML1-ETO to induce acute myeloid leukemia in mice.","volume":"108","author":"Wang","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"2019111808002015500_B19","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1182\/blood-2002-04-1010","article-title":"Implications of somatic mutations in the AML1 gene in radiation-associated and therapy-related myelodysplastic syndrome\/acute myeloid leukemia.","volume":"101","author":"Harada","year":"2003","journal-title":"Blood"},{"issue":"34","key":"2019111808002015500_B20","doi-asserted-by":"crossref","first-page":"5229","DOI":"10.1038\/sj.onc.1206600","article-title":"SUV39H1 interacts with AML1 and abrogates AML1 transactivity. AML1 is methylated in vivo.","volume":"22","author":"Chakraborty","year":"2003","journal-title":"Oncogene"},{"issue":"20","key":"2019111808002015500_B21","doi-asserted-by":"crossref","first-page":"7174","DOI":"10.1073\/pnas.0502130102","article-title":"Point mutation in AML1 disrupts subnuclear targeting, prevents myeloid differentiation, and effects a transformation-like phenotype.","volume":"102","author":"Vradii","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"2019111808002015500_B22","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1046\/j.1523-1755.1998.00935.x","article-title":"The Wilms' tumor suppressor WT1: approaches to gene function.","volume":"53","author":"Menke","year":"1998","journal-title":"Kidney Int"},{"issue":"5","key":"2019111808002015500_B23","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0092-8674(01)00271-9","article-title":"Structural analyses of DNA recognition by the AML1\/Runx-1 Runt domain and its allosteric control by CBFbeta.","volume":"104","author":"Tahirov","year":"2001","journal-title":"Cell"},{"issue":"2","key":"2019111808002015500_B24","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1182\/blood-2004-08-3280","article-title":"Loss of Runx1 perturbs adult hematopoiesis and is associated with a myeloproliferative phenotype.","volume":"106","author":"Growney","year":"2005","journal-title":"Blood"},{"issue":"2","key":"2019111808002015500_B25","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0092-8674(00)80986-1","article-title":"AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis.","volume":"84","author":"Okuda","year":"1996","journal-title":"Cell"},{"issue":"9","key":"2019111808002015500_B26","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1182\/blood.V96.9.3154","article-title":"Mutations of the AML1 gene in myelodysplastic syndrome and their functional implications in leukemogenesis.","volume":"96","author":"Imai","year":"2000","journal-title":"Blood"},{"issue":"12","key":"2019111808002015500_B27","doi-asserted-by":"crossref","first-page":"8085","DOI":"10.1128\/MCB.14.12.8085","article-title":"Identification of a region which directs the monocytic activity of the colony-stimulating factor 1 (macrophage colony-stimulating factor) receptor promoter and binds PEBP2\/CBF (AML1).","volume":"14","author":"Zhang","year":"1994","journal-title":"Mol Cell Biol"},{"issue":"11","key":"2019111808002015500_B28","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S0145-2126(98)00105-2","article-title":"Identification of an upstream enhancer containing an AML1 site in the human myeloperoxidase (MPO) gene.","volume":"22","author":"Austin","year":"1998","journal-title":"Leukemia Research"},{"issue":"4","key":"2019111808002015500_B29","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1002\/jcb.20548","article-title":"Subnuclear targeting of Runx1 is required for synergistic activation of the myeloid specific M-CSF receptor promoter by PU. 1.","volume":"96","author":"Li","year":"2005","journal-title":"J Cell Biochem"},{"issue":"8","key":"2019111808002015500_B30","doi-asserted-by":"crossref","first-page":"4220","DOI":"10.1128\/MCB.17.8.4220","article-title":"A conserved tissue-specific structure at a human T-cell receptor beta-chain core promoter.","volume":"17","author":"Halle","year":"1997","journal-title":"Mol Cell Biol"},{"issue":"2","key":"2019111808002015500_B31","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/jcp.22240","article-title":"The human SWI\/SNF complex associates with RUNX1 to control transcription of hematopoietic target genes.","volume":"225","author":"Bakshi","year":"2010","journal-title":"J Cell Physiol"},{"issue":"5","key":"2019111808002015500_B32","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.4049\/jimmunol.158.5.2251","article-title":"AML1A and AML1B can transactivate the human IL-3 promoter.","volume":"158","author":"Uchida","year":"1997","journal-title":"J Immunol"},{"issue":"18","key":"2019111808002015500_B33","doi-asserted-by":"crossref","first-page":"13542","DOI":"10.1074\/jbc.M700074200","article-title":"RUNX1-RUNX1 homodimerization modulates RUNX1 activity and function.","volume":"282","author":"Li","year":"2007","journal-title":"J Biol Chem"},{"issue":"12","key":"2019111808002015500_B34","doi-asserted-by":"crossref","first-page":"7259","DOI":"10.1128\/MCB.18.12.7259","article-title":"A role for Groucho tetramerization in transcriptional repression.","volume":"18","author":"Chen","year":"1998","journal-title":"Mol Cell Biol"},{"issue":"5203","key":"2019111808002015500_B35","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1126\/science.7878469","article-title":"Crystal structure of the tetramerization domain of the p53 tumor suppressor at 1.7 angstroms.","volume":"267","author":"Jeffrey","year":"1995","journal-title":"Science"},{"issue":"3","key":"2019111808002015500_B36","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1128\/MCB.19.3.1910","article-title":"The significance of tetramerization in promoter recruitment by Stat5.","volume":"19","author":"John","year":"1999","journal-title":"Mol Cell Biol"},{"issue":"1","key":"2019111808002015500_B37","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/emboj\/16.1.69","article-title":"A domain of TEL conserved in a subset of ETS proteins defines a specific oligomerization interface essential to the mitogenic properties of the TEL-PDGFR beta oncoprotein.","volume":"16","author":"Jousset","year":"1997","journal-title":"EMBO J"},{"issue":"5","key":"2019111808002015500_B38","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S1097-2765(00)80321-4","article-title":"Oligomerization of RAR and AML1 transcription factors as a novel mechanism of oncogenic activation.","volume":"5","author":"Minucci","year":"2000","journal-title":"Molecular Cell"},{"issue":"8","key":"2019111808002015500_B39","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1073\/pnas.0810558106","article-title":"Transforming activity of AML1-ETO is independent of CBF beta and ETO interaction but requires formation of homo-oligomeric complexes.","volume":"106","author":"Kwok","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"17","key":"2019111808002015500_B40","doi-asserted-by":"crossref","first-page":"7603","DOI":"10.1158\/0008-5472.CAN-05-0412","article-title":"The distal zinc finger domain of AML1\/MDS1\/EVI1 is an oligomerization domain involved in induction of hematopoietic differentiation defects in primary cells in vitro.","volume":"65","author":"Senyuk","year":"2005","journal-title":"Cancer Res"},{"issue":"4","key":"2019111808002015500_B41","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1182\/blood.V99.4.1364","article-title":"In vitro analyses of known and novel RUNX1\/AML1 mutations in dominant familial platelet disorder with predisposition to acute myelogenous leukemia: implications for mechanisms of pathogenesis.","volume":"99","author":"Michaud","year":"2002","journal-title":"Blood"},{"issue":"3","key":"2019111808002015500_B42","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1128\/MCB.15.3.1651","article-title":"Subcellular localization of the alpha-subunits and beta-subunits of the acute myeloid leukemia-linked transcription factor Pebp2\/Cbf.","volume":"15","author":"Lu","year":"1995","journal-title":"Mol Cell Biol"},{"issue":"24","key":"2019111808002015500_B43","doi-asserted-by":"crossref","first-page":"4284","DOI":"10.1038\/sj.onc.1207779","article-title":"Point mutations in the RUNX1\/AML1 gene: another actor in RUNX leukemia.","volume":"23","author":"Osato","year":"2004","journal-title":"Oncogene"},{"issue":"25","key":"2019111808002015500_B44","doi-asserted-by":"crossref","first-page":"5201","DOI":"10.1182\/blood-2009-06-223982","article-title":"AML1\/RUNX1 point mutation possibly promotes leukemic transformation in myeloproliferative neoplasms.","volume":"114","author":"Ding","year":"2009","journal-title":"Blood"},{"issue":"8","key":"2019111808002015500_B45","doi-asserted-by":"crossref","first-page":"4297","DOI":"10.1182\/blood-2007-01-068346","article-title":"AML1 mutations induced MDS and MDS\/AML in a mouse BMT model.","volume":"111","author":"Watanabe-Okochi","year":"2008","journal-title":"Blood"},{"issue":"5","key":"2019111808002015500_B46","doi-asserted-by":"crossref","first-page":"e172","DOI":"10.1371\/journal.pmed.0040172","article-title":"Isoform-specific potentiation of stem and progenitor cell engraftment by AML1\/RUNX1.","volume":"4","author":"Tsuzuki","year":"2007","journal-title":"PLoS Med"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/119\/12\/2873\/1350331\/zh801212002873.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/119\/12\/2873\/1350331\/zh801212002873.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T11:46:26Z","timestamp":1686743186000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/119\/12\/2873\/29831\/Functional-features-of-RUNX1-mutants-in-acute"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,22]]},"references-count":46,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2012,3,22]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2011-08-370981","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,22]]}}}